Cardiovascular System in Obesity: Effect of Treatment
Completed
National Heart, Lung, and Blood Institute (NHLBI)
Phase 2
1983-05-01
To determine the long-term efficacy of the combination therapy of phentermine and
fenfluramine in conjunction with diet, exercise, and behavior modification in the treatment
of simple, moderate obesity.
Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity
Completed
Eisai Inc.
Phase 3
2005-08-01
The specific aim of this study is to examine the efficacy and safety of zonisamide compared
with placebo in outpatients with binge eating disorder associated with obesity.
Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity
Completed
University of Cincinnati
Phase 3
2005-08-01
The specific aim of this study is to examine the efficacy and safety of zonisamide compared
with placebo in outpatients with binge eating disorder associated with obesity.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
